Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial.

Yasemin Taş Torun Yasemen Işik Taner Esra Guney Elvan Işeri

Published in: Applied neuropsychology. Child (2020)

Atomoxetine and OROS-MPH treatments have shown similar efficacy in clinical recovery and improvement on executive functions. However, disturbances in executive functions observed in children with ADHD are persistent despite treatment, when compared with the control group.

Keyphrases

attention deficit hyperactivity disorder
working memory
autism spectrum disorder
randomized controlled trial
systematic review
young adults
combination therapy